FRSH
Freshworks Inc.
FRSH's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over FRSH overall, supported by stronger valuation and stronger modeled upside.
FRSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
FRSH's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
FRSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $9.39 | -26% |
| Forward | 15x | $12.67 | — |
| Fair | 16x | $11.78 | -7.1% |
| Current | 18x | $12.67 | — |
| Expensive | 20x | $14.57 | +15% |
Historical ranges are pointers, not guarantees.
FRSH's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over FRSH in the historical PE scenario, which offers more potential upside but is not a forecast.
FRSH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
FRSH has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
FRSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.84 | +17% |
| Q3 2026 | $0.72 | +$0.82 |
| Q2 2026 | $0.63 | +$0.81 |
| Q1 2026 | $0.61 | +$0.85 |
| Q4 2025 | $0.63 | +$0.95 |
| Q3 2025 | -$0.10 | +$0.24 |
| Q2 2025 | -$0.18 | +$0.17 |
| Q1 2025 | -$0.24 | +$0.16 |
| Q4 2024 | -$0.32 | +$0.15 |
FRSH has returned to profit: it earned $0.72 per share over the past year, after losing money the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA's earnings per share have climbed steadily: $7.91 over the past year, up 125% from the year before, and higher year over year for 13 quarters in a row.
FRSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $245.4M | +14% |
| Q2 2026 | $237.4M | +16% |
| Q1 2026 | $228.6M | +16% |
| Q4 2025 | $222.7M | +14% |
| Q3 2025 | $215.1M | +15% |
| Q2 2025 | $204.7M | +18% |
| Q1 2025 | $196.3M | +19% |
| Q4 2024 | $194.6M | +22% |
FRSH's revenue has grown year over year every quarter since late 2020: $245M last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +15 points |
| Q2 2026 | 2.5% | +6.8 points |
| Q1 2026 | -3.5% | +1.8 points |
| Q4 2025 | 18% | +30 points |
| Q3 2025 | -3.5% | +17 points |
| Q2 2025 | -4.2% | +21 points |
| Q1 2025 | -5.3% | +14 points |
| Q4 2024 | -12% | +13 points |
FRSH's operating margin was 12% last quarter, up 15 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over FRSH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over FRSH on profitability, with a higher operating margin.
FRSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $74.9M | +21% |
| Q2 2026 | $53.5M | -8.1% |
| Q1 2026 | $58.5M | +3.2% |
| Q4 2025 | $60.1M | +66% |
| Q3 2025 | $61.7M | +49% |
| Q2 2025 | $58.2M | +71% |
| Q1 2025 | $56.7M | +42% |
| Q4 2024 | $36.3M | +22% |
FRSH generated $247M in free cash flow over the past year, up 16% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over FRSH on cash flow, with stronger typical year-over-year growth.
FRSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -6.6M shares |
| 1 year | -6.9% | -19.8M shares |
| 3 years | -9.4% | -27.8M shares |
| 5 years | +5.3% | +13.5M shares |
| Available history | +1468% | +249M shares |
FRSH has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $27.2M |
| Q2 2026 | $159M |
| Q1 2026 | $48.4M |
| Q4 2025 | — |
| Q3 2025 | $159.1M |
| Q2 2025 | $113.6M |
| Q1 2025 | $113.6M |
| Q2 2021 | — |
FRSH spent $235M buying back its own shares over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
FRSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.8x | Net Cash |
| Q2 2026 | -8.3x | Net Cash |
| Q1 2026 | -12.8x | Net Cash |
| Q4 2025 | -14.6x | Net Cash |
| Q2 2021 | -122.9x | Net Cash |
| Q1 2021 | -101.8x | Net Cash |
| Q1 2019 | 6.2x | High |
FRSH has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
FRSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.8 | Neutral |
| Stochastic | 46.5 | Neutral |
FRSH's weekly RSI is 53 (neutral) and its Stochastic is 47 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
FRSH PE vs Technology Sector
| Metric | FRSH | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 28x | 37% below |
| PE % | 62 | 45 | 17 pts above |
FRSH has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
FRSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.5 | 6.1% below |
| 20 week MA | $12.5 | 1.6% above |
| 50 week MA | $10.8 | 18% above |
| 100 week MA | $12.5 | 1.4% above |
| 200 week MA | $14.5 | 13% below |
FRSH has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
FRSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $46.8 | $27.9 | -40% |
| 2022 | $27.9 | $13.8 | -50% |
| 2023 | $13.8 | $23.5 | +70% |
| 2024 | $23.5 | $15.9 | -32% |
| 2025 | $15.9 | $12.4 | -22% |
| 2026 YTD | $12.4 | $12.7 | +2.2% |
FRSH has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.